Market closedRefreshes 15sData NSENot investment advice
Narayana Hrudayalaya

Narayana Hrudayalaya

NSE: NHBSE 539551Healthcarewww.narayanahealth.org
View MapTV Chart
1,869.00
25.90+1.41%
DAY1,835
₹1,869.00
1,880
52W1,589
₹1,869.00
2,370
Open1,836.30
Prev Close1,843.10
Bid1,868.91102
Ask1,869.09100
Volume254.6K36%vs 20D avg
Market Cap₹38,215.47 Cr
Promoter Hold.63.8%
Face Value₹10
Fwd P/E26.27
PEG
EV/EBITDA24.79
P/S4.74
ROA7.4%
Beta0.18
Div Payout11.28%
Valuation

Narayana Hrudayalaya Ltd valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for Narayana Hrudayalaya Ltd, framed against the sector median so the premium or discount is obvious at a glance.

Narayana Hrudayalaya Ltd trades at a P/E of 46.24× and P/B of 8.25×.

Key MetricsLive · as of 18 Jun 2026
the price tag

Valuation

Market Cap
₹38,215.47 Cr
P/E Ratio
watch46.24
P/B Ratio
watch8.25
EPS
39.86
the engine

Profitability

ROE
good19.85%
ROCE
good20.8%
Net Margin
good10.2%
Op Margin
avg14.8%
the trajectory

Growth

EPS YoY
avg13.5%
Revenue YoY
good75.8%
Qtr Sales
good15.4%
Qtr Profit
watch-2.26%
the balance sheet

Financial Health

Debt / Equity
watch129.03
Book Value
223.34
Div Yield
avg0.24%
Promoter Hold.
good63.8%
Financials

Narayana Hrudayalaya Ltd financials: P&L, balance sheet, cash flow, ratios.

Twelve years of audited numbers for Narayana Hrudayalaya Ltd, switchable between annual and quarterly views, consolidated or standalone.

Narayana Hrudayalaya Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹38,215.47 Cr and reported EPS of ₹39.86.

Period201820192020202120222023202420252026
Revenue from Operations
2,281
2,861
3,128
2,582
3,701
4,525
5,018
5,483
7,896
Other Income
19
17
24
28
35
65
75
92
100
Total Income
2,300
2,878
3,152
2,611
3,736
4,590
5,093
5,575
7,996
Cost of Goods Sold (COGS)
557
688
745
678
909
1,001
1,074
1,136
1,516
Gross Profit
1,724
2,173
2,382
1,904
2,792
3,524
3,944
4,347
6,380
+Operating Expenses
1,512
1,886
1,960
1,722
2,139
2,558
2,792
3,070
4,763
EBITDA
212
288
423
182
654
966
1,152
1,276
1,617
+Non-Operating Expenses
147
209
260
253
241
279
339
416
641
Profit Before Tax (PBT)
85
96
165
-56
430
752
889
936
974
+Tax Expense
29
34
42
-42
88
145
99
146
158
Profit After Tax (PAT)
51
59
119
-14
342
607
790
791
806
Earnings Per Share (EPS)
2.51
2.90
5.82
-0.70
16.73
29.67
38.62
38.66
39.42
Diluted Shares Outstanding (Nos.)
20
20
20
20
20
20
20
20
20
+Additional Disclosures
2,771
3,467
3,723
3,336
4,233
4,897
5,293
5,803
8,680
Sales Growth %
25.43
9.33
-17.44
43.33
22.25
10.91
9.26
44.01
YoY Sales Growth %
25.43
9.33
-17.44
43.33
22.25
10.91
9.26
44.01
Employee Cost %
20
22
22
24
21
19
20
20
23
Other Cost %
46
44
41
42
37
37
36
36
37
OPM %
9
10
14
7
18
21
23
23
20
Tax %
34
36
26
75
20
19
11
16
16
Profit Growth %
15.32
100.84
-112.01
2,493.45
77.30
30.18
0.13
1.94
Gross Margin %
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA Margin %
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Coverage Ratio
0.00
0.00
0.00
-0.00
0.00
0.00
0.00
0.00
0.00
Additional Fields
112
150
237
-1
470
756
910
998
1,169
all values in ₹ Cr unless suffixed · source: company filings
Segment Analysis

Narayana Hrudayalaya segment analysis: revenue and profit mix.

Disclosed business segments at Narayana Hrudayalaya with their share of revenue and profit, switchable between consolidated and standalone reporting.

Narayana Hrudayalaya discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Investment Thesis

Narayana Hrudayalaya Ltd investment thesis: bull case, bear case, and the flip lines.

Why someone would buy Narayana Hrudayalaya Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.

Narayana Hrudayalaya Ltd's investment case rests on 4 positive markers and 4 flagged concerns drawn from the latest reported filings.

bull case

What you're getting.

  • Narayana Hrudayalaya demonstrates robust profitability with a strong Return on Equity (ROE) of 24.20% and Return on Capital Employed (ROCE) of 20.80%, showcasing efficient capital utilization and operational excellence.

  • The company exhibits consistent growth in quarterly sales, with a 15.40% increase, indicating strong demand for its healthcare services and a solid market position within the competitive industry.

  • A significant promoter holding of 63.85% reflects strong internal confidence and commitment to the company's long-term vision, providing stability and reducing risks of hostile takeovers.

  • With a P/E ratio of 46.50, the company trades below the sector P/E of 51.10 and most peers, potentially indicating an attractive valuation relative to its industry and growth prospects.

bear case

What can break it.

  • Despite healthy sales growth, the company reported a slight decline in quarterly profit by -2.26%, suggesting potential pressure on margins or increased operational costs that warrant closer examination.

  • The debt-to-equity ratio of 0.67, while moderate, indicates a reliance on borrowed capital which could elevate financial risk, particularly during periods of economic uncertainty or rising interest rates.

  • There's a noticeable trend of decreasing FII and DII holdings, alongside an increasing public shareholding, which might signal a shift in institutional investor sentiment over recent periods.

  • The stock has shown considerable volatility, trading between a 52-week high of ₹2372 and a low of ₹1185, which could expose investors to significant price fluctuations and market risk.

flip conditions

What would change my mind.

  • Trim if P/E re-rates above 60. The valuation cushion thins from there.

  • Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 129.53. Balance sheet risk re-prices growth multiples fast.

  • Exit if ROE slips below 15%. The operating engine is no longer compounding capital efficiently.

Shareholding

Narayana shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in Narayana — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Loading shareholding data...

Peers

Narayana Hrudayalaya Ltd peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Narayana Hrudayalaya Ltd is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
Apollo Hospitals Enterprise Ltd
₹1.21 Lakh Cr
Best Profit Growth
Dr Agarwals Health Care Ltd
151.00 %
Highest Dividend Yield
GPT Healthcare Ltd
2.04 %
Technicals

Narayana Hrudayalaya Ltd technical analysis: indicators, pivots and CPR.

Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Narayana Hrudayalaya Ltd — derived from the live tape, not yesterday's close.

Narayana Hrudayalaya Ltd last traded at ₹1,869 with an intraday range of ₹1,835–₹1,879.8 — live indicator, pivot and CPR signals below.

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Live: ₹1869.00
LevelPrice (₹)Distance% Δ
R41977.13+108.13+5.79%
R31932.33+63.33+3.39%
R21906.07+37.07+1.98%
R11887.53+18.53+0.99%
PIVOT1861.27-7.73-0.41%
CURRENT1869.00
S11753.13-115.87-6.20%
S21797.93-71.07-3.80%
S31816.47-52.53-2.81%
S41842.73-26.27-1.41%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 1857.40P: 1861.27TC: 1865.13
R1
R2
R3
R4
indicator
LTP: 1869.00
PDH: 1872.90
PDL: 1833.60
● Market Sentiment

NH is trading Above CPR, indicating Bullishness

● CPR Width

CPR is Average

● Opening Range

Day's range: 1835 ~ 1850

● Price Position

Trading Inside opening range

Chart Patterns

Narayana Hrudayalaya Ltd chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for Narayana Hrudayalaya Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Delivery & Volume

Narayana Hrudayalaya Ltd delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for Narayana Hrudayalaya Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in Narayana Hrudayalaya Ltd stood at 58.5% of traded volume, against a 20-day average of 53.3%.

Avg Delivery (20D)53.3%+5.2 ppt latest vs avg
Highest Delivery65.5%on 29 May
Avg Volume (20D)3.96 L20-day run-rate
Conviction Trend↑ Strengthening+5.2 ppt latest read
Volume & Delivery · last 20 sessions
Filings & Concalls

Narayana Hrudayalaya announcements: results, concalls, ratings, M&A.

Filings Narayana Hrudayalaya sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

Narayana Hrudayalaya files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 151 documents below.

  1. 05 Jun 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Narayana Hrudayalaya Ltd. has informed the Exchange about schedule of a group investor meeting to be held on June 11, 2026.

  2. 05 Jun 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Narayana Hrudayalaya Ltd. has informed the Exchange about Schedule of a group investor meeting to be held on June 10, 2026.

  3. 02 Jun 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Narayana Hrudayalaya Ltd. has informed the Exchange about Transcript of the Earnings call of the company for the quarter and financial year ended…

  4. 06 Apr 2026General UpdatesView PDF

    General Updates

    Narayana Hrudayalaya Ltd. has informed the Exchange regarding submission of the revised Scrutinizer's Report for the General Meeting of the Equity…

  5. 06 Apr 2026Shareholders meetingView PDF

    Shareholders meeting

    Submission of revised Scrutinizer's report of General Meeting of the Equity Shareholders of the Company held on April 02, 2026 pursuant to the Order…

Corporate Actions

Narayana Hrudayalaya dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue Narayana Hrudayalaya has declared, sequenced by announce and record date.

Narayana Hrudayalaya corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About Narayana Hrudayalaya Ltd: business, sector, key facts.

What Narayana Hrudayalaya Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

Narayana Hrudayalaya Ltd operates in the Healthcare, listed as NSE: NH, BSE: 539551.

NH
Healthcare

Narayana Hrudayalaya Ltd

NSE · NH·BSE · 539551·www.narayanahealth.org

Narayana Hrudayalaya Limited (NH) is a major player in the Indian healthcare sector, with a global reach. Its core business revolves around providing a wide range of medical and healthcare services. This includes the ownership and operation of a network of hospitals, clinics, diagnostic centers, and other healthcare facilities. NH's extensive network allows it to serve a substantial patient population across diverse geographical locations.

The company's service offerings are comprehensive, spanning a vast spectrum of medical specialties. These include cardiology and cardiac surgery, representing a significant area of focus, alongside nephrology, urology, neurology, neurosurgery, endocrinology, orthopedics, internal medicine, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology. This breadth of services allows NH to cater to a diverse range of patient needs and health conditions.

NH operates through two primary segments: Medical and Healthcare Related Services, and Others. The "Medical and Healthcare Related Services" segment encompasses the core operations of providing direct patient care across its numerous facilities. The "Others" segment likely includes supporting business activities, which may involve ancillary services, administrative functions, or other revenue streams outside of direct medical provision. The specific nature of the "Others" segment isn't detailed in the provided source.

Beyond direct patient care, NH also has a presence in the health insurance sector. This diversification allows the company to engage in a broader range of healthcare-related activities, potentially offering integrated solutions for patients and further strengthening its position within the market. This vertical integration likely contributes to a more robust and resilient business model.

Established in 2000 and headquartered in Bengaluru, India, NH has grown significantly over the years, establishing itself as a prominent healthcare provider in India and expanding internationally. Its continued growth and success are built upon a foundation of delivering comprehensive medical services across a wide range of specialties, complemented by its diversification into health insurance.

company facts
Founded / IPO
Employees
SectorHealthcare
HeadquartersBengaluru, India
Market Cap₹38,215.47 Cr
Listed OnNSE
leadership22 on record
Dr. Anesh Shetty
Non-Executive Director
Dr. Devi Prasad Shetty M.S.
Founder & Executive Chairman
Dr. Devi Shetty
Executive Chairman of the Board, Whole Time Director
Dr. Emmanuel Rupert
Group Chief Executive Officer, Managing Director, Executive Director
Dr. Emmanuel Rupert
MD, Group CEO & Director
Dr. Kiran Mazumdar Shaw
Non-Executive Director
Dr. Nachiket Mor
Non-Executive Independent Director
Mr. Ashish Bajaj
Group Chief Marketing Officer
Mr. Kumar Krishnamurthy Venkateswaran
Group Head Information Technology & Chief Information Officer
Mr. Naveen Tewari
Non-Executive Independent Director
Mr. Nishant Singh
Vice President of Finance, Mergers & Acquisitions and Investor Relations
Mr. R. Venkatesh
Group Chief Operating Officer
§ ∞ · Plainly Answered

Questions investors ask about Narayana Hrudayalaya Ltd (NH).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of Narayana Hrudayalaya Ltd (NH)?

The current share price of Narayana Hrudayalaya Ltd (NH) is ₹1,869. Today, the stock has gained by ₹25.90 (1.41%), trading in a range of ₹1,835 to ₹1,879.8. The stock opened at ₹1,836.3 with a trading volume of 2,54,576 shares.

02Is Narayana Hrudayalaya Ltd stock a good investment for long-term?

Narayana Hrudayalaya Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹38,215.47 crores, P/E ratio of 46.24, ROE of 19.85%, and ROCE of 20.80%. The dividend yield stands at 0.24%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of Narayana Hrudayalaya Ltd stock?

The 52-week high price of Narayana Hrudayalaya Ltd (NH) is ₹2,370.2, while the 52-week low is ₹1,589. Currently trading at ₹1,869, the stock is 35.8% away from its 52-week low and 21.1% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy Narayana Hrudayalaya Ltd stock at the current price?

Whether to buy Narayana Hrudayalaya Ltd stock at ₹1,869 depends on multiple factors. The stock is currently trading with a P/E ratio of 46.24 and P/B ratio of 8.25. Today's performance shows a gain of 1.41%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of Narayana Hrudayalaya Ltd and when is the next dividend?

Narayana Hrudayalaya Ltd offers a dividend yield of 0.24%, which means for every ₹100 invested at the current price of ₹1,869, you can expect to receive approximately ₹0.24 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of Narayana Hrudayalaya Ltd?

Narayana Hrudayalaya Ltd's key financial metrics include: P/E Ratio: 46.24, P/B Ratio: 8.25, ROE: 19.85%, ROCE: 20.80%, Dividend Yield: 0.24%, EPS: ₹39.86, Book Value: ₹223.34, and Debt-to-Equity: 129.03. The company's market cap stands at ₹38,215.47 crores. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is Narayana Hrudayalaya Ltd stock performing today in the market?

Narayana Hrudayalaya Ltd stock opened at ₹1,836.3 and is currently trading at ₹1,869, showing a gain of ₹25.90 (1.41%). The intraday high is ₹1,879.8 and low is ₹1,835. The trading volume stands at 2,54,576 shares, indicating moderate market participation today.

08What is the P/E ratio of Narayana Hrudayalaya Ltd and what does it indicate?

Narayana Hrudayalaya Ltd has a Price-to-Earnings (P/E) ratio of 46.24, which means investors are willing to pay ₹46.24 for every ₹1 of earnings. With an EPS of ₹39.86, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about Narayana Hrudayalaya Ltd (NH) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.